Skip to Main Content

Paper Details

Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial.
J Neural Transm (Vienna)
2
2023
Author NameAffiliation
Peter FalkaiUniversity Hospital
Marion LeboyerINSERM U955, Hopitaux Universitaires Henri Mondor, Departement Medico-Universitaire de Psychiatrie Et d'Addictologie (DMU IMPACT), Federation Hospitalo-Universitaire de Medecine de Precision en Psychiatrie (FHU ADAPT)
  • 1 - 2

Datasets

Release 1.2